Linerixibat decreased serum interleukin-31 levels in patients with primary biliary in cholangitis after 24 weeks, which may ...

The condition, called pruritus, can happen when you stop taking these drugs after long-term daily use. Stopping long-term treatment with the over-the-counter antihistamines Zyrtec or Xyzal may cause ...

In the RESPONSE trial, seladelpar 10 mg once daily significantly reduced itch severity at 6 months compared with placebo (LS ...

This year’s scientific meeting had the highest patient attendance in AASLD history. The patients' message: stigma delays ...

Three-year data from ongoing open-label study supported safety and effectiveness of seladelpar in patients with primary biliary cholangitis.

Gilead’s Livdelzi demonstrates sustained efficacy in PBC, offering ALP reduction, itch relief and potential to slow disease progression: Foster City, California Monday, November ...

New safety and efficacy data for primary biliary cholangitis (PBC) treatment Livdelzi (seladelpar) was presented today at The Liver Meeting, hosted by the American Association for the Study of Liver ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of ...

Gilead (GILD) announced new long-term data reinforcing the safety and efficacy profile of Livdelzi for people living with primary biliary ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

The expansion of the cholestatic pruritus market across the US will be driven by the introduction of innovative therapies, ...

Persistent ear itching can signal various issues, from simple earwax buildup and infections to skin conditions like eczema and psoriasis. Even hearing aids, food allergies, and hay fever can trigger ...